Biofrontera AG Depreciation & Amortization Growth & History (B8FK)
Biofrontera AG's depreciation and amortization was €648,000 for fiscal 2025.
View full Biofrontera AG company overviewBiofrontera AG annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €648,000 | −€191,000 | −22.77% |
| 2024 | 2024-12-31 | €839,000 | €48,000 | +6.07% |
| 2023 | 2023-12-31 | €791,000 | €45,000 | +6.03% |
| 2022 | 2022-12-31 | €746,000 | −€2.5M | −77.33% |
| 2021 | 2021-12-31 | €3.3M | — | — |
Biofrontera AG depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Biofrontera AG's depreciation and amortization decreased from €3.3M to €648,000, a change of −€2.6M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biofrontera AG source filings ↗